Are you a breast cancer survivor? if soy you may be eligible to participate in this research study that is looking at the effectiveness of fisetin and/or exercise on physical function assessed using a 6 minute walking distance in chemotherapy-treated postmenopausal breast cancer survivors
We are studying an investigational drug, Efruxifermin, to see if it will help in the treatment of liver inflammation and scarring (fibrosis) in adults diagnosed with Compensated Cirrhosis due to NASH (non-alcoholic steatohepatitis) and MASH (metabolic dysfunction-associated steatohepatitis).
Do you have With Locally Advanced or Metastatic Solid Tumors of the Head or Neck? If so, you may be able to participate in a research study to to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX 106 administered as a single agent or in combination with the anti-PD-1 checkpoint inhibitor (CPI) pembrolizumab (Keytruda®).
Are you interested in learning more about how the body and brain influences social behavior? If you are between 18 and 29 years old, you may be eligible to participate in our new EEG study! This project uses EEG and blood assaying techniques to understand how differences in immune functioning relates to the way that reward is processed in the brain. Compensation is provided.
Preventing walking disability in our rapidly aging population is an enormous public health challenge. Fundamental to their loss of functional mobility is that the muscles needed to power walking experience disproportionate declines in function with age. Wearable assistive devices can be designed to augment the function of these muscles and may make walking easier. If you are a healthy young adult, you may be eligible to participate in a study to help guide the development of more effective exoskeleton designs!
Do you have non small cell lung cancer? Are you currently not on any other treatments for your cancer? If you answered yes, you may be able to take part in a lung cancer medication study.
In this study, we want to see how patients with metastatic non-small cell lung cancer do with two treatments: ivonescimab and chemotherapy. We are comparing these treatments to find out which one helps patients more.
We are conducting 3 90-minute workshops with young adults who consume alcohol to support the development of an intervention to reduce alcohol use and prevent alcohol-related harms.
In this study, we want to test a new web application we are creating. The app will help users find important information about digital health resources and how ready a community is to use them.
Have you experienced online sexual harassment in the past year? If so, you might be able to take part in a study on how common online sexual harassment is. We want to understand it better and find better ways to measure it in research. Compensation provided.